A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network

E Dale Abel1, Rexford S Ahima2, Ethan J Anderson3

  • 1Department of Medicine, David Geffen School of Medicine, University of California Los Angeles (E.D.A.).

Circulation Research
|January 15, 2026
PubMed

Insights

Patients with diabetes face a doubled risk of cardiovascular issues. Research networks are investigating the underlying mechanisms and seeking new biomarkers to predict and prevent these serious heart complications.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetes mellitus (type 1 and type 2) significantly elevates cardiovascular complication risk.
  • Despite advances, the mechanisms linking diabetes to heart disease remain incompletely understood.
  • Atherosclerotic cardiovascular disease and heart failure are major concerns in diabetic populations.

Purpose of the Study:

  • To review current research on why diabetes accelerates atherosclerotic cardiovascular disease and heart failure.
  • To integrate findings from the Strategically Focused Research Network on Cardiometabolic Health and Type 2 Diabetes.
  • To identify novel risk factors and suggest future research directions.

Main Methods:

  • Review of basic, translational, and clinical studies.
  • Analysis of human population data for biomarker discovery.
  • Consideration of experimental models (cell and animal studies).
  • Integration of findings from four leading research centers.

Main Results:

  • Diabetes confers over a 2-fold increased risk of cardiovascular complications.
  • Ongoing research aims to uncover novel disease mechanisms and prognostic biomarkers.
  • Human data and experimental models provide complementary insights into diabetes-driven heart disease.

Conclusions:

  • Understanding the link between diabetes and cardiovascular disease requires multifaceted research approaches.
  • Identifying new risk factors and biomarkers is crucial for improved patient outcomes.
  • Continued investigation into cardiometabolic health in diabetes is essential for prevention and treatment strategies.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
621
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
122
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
45
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
66